Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Compass Therapeutics, Inc. (CMPX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Compass Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1738021.
Total stock buying since 2020: $60,603,256.
Total stock sales since 2020: $11,460,846.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 50,000 | $80,300 | 7,142,856 | $11,357,140 | 0 | $0 |
| 2023 | 90,000 | $355,300 | 0 | $0 | 0 | $0 |
| 2022 | 1,746,156 | $4,613,261 | 24,500 | $103,706 | 0 | $0 |
| 2021 | 10,714,286 | $37,500,000 | 0 | $0 | 0 | $0 |
| 2020 | 3,610,879 | $18,054,395 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 10,000 | $21,100 | 0 | $0 | 0 | $0 |
| 2025-04 | 40,000 | $59,200 | 7,142,856 | $11,357,140 | 0 | $0 |
| 2023-03 | 10,000 | $33,700 | 0 | $0 | 0 | $0 |
| 2023-02 | 40,000 | $156,800 | 0 | $0 | 0 | $0 |
| 2023-01 | 40,000 | $164,800 | 0 | $0 | 0 | $0 |
| 2022-11 | 804,000 | $2,580,840 | 24,500 | $103,706 | 0 | $0 |
| 2022-09 | 55,000 | $145,150 | 0 | $0 | 0 | $0 |
| 2022-08 | 45,000 | $124,050 | 0 | $0 | 0 | $0 |
| 2022-06 | 120,000 | $316,999 | 0 | $0 | 0 | $0 |
| 2022-05 | 722,156 | $1,446,222 | 0 | $0 | 0 | $0 |
| 2021-11 | 10,714,286 | $37,500,000 | 0 | $0 | 0 | $0 |
| 2020-06 | 3,610,879 | $18,054,395 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-27 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 10,000 | 2.11 | 21,100 |
| 2025-04-09 | Orbimed Genesis Gp Llc | Sale | 3,571,428 | 1.59 | 5,678,570 |
| 2025-04-09 | Gordon Carl L | Sale | 3,571,428 | 1.59 | 5,678,570 |
| 2025-04-07 | Anderman Jonathan (Gen Counsel & Corporate Sec) | Buy | 20,000 | 1.54 | 30,800 |
| 2025-04-07 | Lerner Neil (CHIEF ACCOUNTING OFFICER) | Buy | 20,000 | 1.42 | 28,400 |
| 2023-03-10 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 10,000 | 3.37 | 33,700 |
| 2023-02-27 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 3.98 | 79,600 |
| 2023-02-15 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 3.86 | 77,200 |
| 2023-01-31 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 4.05 | 81,000 |
| 2023-01-24 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 4.19 | 83,800 |
| 2022-11-25 | Bisker-leib Vered (Chief Operating Officer) | Sale | 2 | 4.36 | 8 |
| 2022-11-23 | Bisker-leib Vered (Chief Operating Officer) | Sale | 9,569 | 4.30 | 41,146 |
| 2022-11-22 | Bisker-leib Vered (Chief Operating Officer) | Sale | 14,929 | 4.19 | 62,552 |
| 2022-11-08 | Orbimed Genesis Gp Llc | Buy | 402,000 | 3.21 | 1,290,420 |
| 2022-11-08 | Gordon Carl L | Buy | 402,000 | 3.21 | 1,290,420 |
| 2022-09-28 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 10,000 | 2.32 | 23,200 |
| 2022-09-26 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 2.27 | 34,050 |
| 2022-09-07 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 3.03 | 45,450 |
| 2022-09-01 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 2.83 | 42,450 |
| 2022-08-17 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 3.05 | 45,750 |
| 2022-08-10 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 2.64 | 39,600 |
| 2022-08-01 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 15,000 | 2.58 | 38,700 |
| 2022-06-21 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 2.80 | 56,000 |
| 2022-06-16 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 2.34 | 46,800 |
| 2022-06-13 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 30,000 | 2.29 | 68,700 |
| 2022-06-06 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 30,000 | 2.83 | 84,900 |
| 2022-06-01 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 3.03 | 60,599 |
| 2022-05-26 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 3.04 | 60,800 |
| 2022-05-23 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 18,355 | 2.72 | 49,925 |
| 2022-05-17 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 20,215 | 2.47 | 49,931 |
| 2022-05-13 | Orbimed Genesis Gp Llc | Buy | 30,722 | 2.49 | 76,497 |
| 2022-05-13 | Gordon Carl L | Buy | 30,722 | 2.49 | 76,497 |
| 2022-05-12 | Orbimed Genesis Gp Llc | Buy | 97,094 | 2.35 | 228,170 |
| 2022-05-12 | Gordon Carl L | Buy | 97,094 | 2.35 | 228,170 |
| 2022-05-11 | Orbimed Genesis Gp Llc | Buy | 64,700 | 1.79 | 115,813 |
| 2022-05-11 | Gordon Carl L | Buy | 64,700 | 1.79 | 115,813 |
| 2022-05-10 | Orbimed Genesis Gp Llc | Buy | 24,447 | 1.60 | 39,115 |
| 2022-05-10 | Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) | Buy | 27,836 | 1.80 | 50,104 |
| 2022-05-10 | Gordon Carl L | Buy | 24,447 | 1.60 | 39,115 |
| 2022-05-09 | Orbimed Genesis Gp Llc | Buy | 90,712 | 1.56 | 141,510 |
| 2022-05-09 | Gordon Carl L | Buy | 90,712 | 1.56 | 141,510 |
| 2022-05-06 | Orbimed Genesis Gp Llc | Buy | 10,200 | 1.63 | 16,626 |
| 2022-05-06 | Gordon Carl L | Buy | 10,200 | 1.63 | 16,626 |
| 2021-11-04 | Orbimed Genesis Gp Llc | Buy | 5,357,143 | 3.50 | 18,750,000 |
| 2021-11-04 | Gordon Carl L | Buy | 5,357,143 | 3.50 | 18,750,000 |
| 2020-06-19 | Ferneau Philip | Buy | 314,066 | 5.00 | 1,570,330 |
| 2020-06-19 | Sunderland Julie | Buy | 289,118 | 5.00 | 1,445,590 |
| 2020-06-19 | Orbimed Capital Gp V Llc | Buy | 1,455,132 | 5.00 | 7,275,660 |
| 2020-06-19 | Schuetz Thomas J. (Chief Executive Officer) | Buy | 97,431 | 5.00 | 487,155 |
| 2020-06-19 | Gordon Carl L | Buy | 1,455,132 | 5.00 | 7,275,660 |
Insider trading activities including stock purchases, stock sales, and option exercises of CMPX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Compass Therapeutics, Inc. (symbol CMPX, CIK number 1738021) see the Securities and Exchange Commission (SEC) website.